DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis

Journal Article · · Nature Communications
 [1]; ORCiD logo [2];  [1];  [3];  [1];  [2];  [4];  [1];  [5];  [5];  [6];  [1];  [1];  [3];  [3];  [6];  [5];  [7];  [2];  [6] more »;  [8] « less
  1. Istituto Superiore di Sanità, Rome (Italy)
  2. Univ. of California, Los Angeles, CA (United States)
  3. Univ. of Tor Vergata, Rome (Italy)
  4. Univ. of Geneva (Switzerland)
  5. Univ. La Sapienza, Rome (Italy)
  6. Univ. Hospital and School of Medicine, Geneva (Switzerland)
  7. Univ. Hospital, Bordeaux (France)
  8. Istituto Superiore di Sanità, Rome (Italy); Univ. Hospital and School of Medicine, Geneva (Switzerland)

Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and vasculopathy. CXCL4 represents an early serum biomarker of severe SSc and likely contributes to inflammation via chemokine signaling pathways, but the exact role of CXCL4 in SSc pathogenesis is unclear. Here, we elucidate an unanticipated mechanism for CXCL4-mediated immune amplification in SSc, in which CXCL4 organizes “self” and microbial DNA into liquid crystalline immune complexes that amplify TLR9-mediated plasmacytoid dendritic cell (pDC)-hyperactivation and interferon-α production. Surprisingly, this activity does not require CXCR3, the CXCL4 receptor. Importantly, we find that CXCL4-DNA complexes are present in vivo and correlate with type I interferon (IFN-I) in SSc blood, and that CXCL4-positive skin pDCs coexpress IFN-I-related genes. Thus, we establish a direct link between CXCL4 overexpression and the IFN-I-gene signature in SSc and outline a paradigm in which chemokines can drastically modulate innate immune receptors without being direct agonists.

Research Organization:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); Swiss National Science Foundation (SNF); Ernst et Lucie Schmidheiny Foundation; Carlos et Elsie De Reuter Foundation; Fondazione Roma; Ricerca Finalizzata; National Institutes of Health (NIH); National Psoriasis Foundation
Grant/Contract Number:
AC02-76SF00515; 310030-159999; CO-2013-02356463; T32GM008185
OSTI ID:
1624151
Journal Information:
Nature Communications, Vol. 10, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (64)

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide journal September 2007
TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 journal July 2015
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons journal November 2010
Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin journal February 2005
Neutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages journal June 2003
The role of genetics and epigenetics in the pathogenesis of systemic sclerosis journal August 2014
Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis journal April 2015
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 journal August 2009
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative journal October 2013
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator journal April 1985
Neutrophil accumulation and NET release contribute to thrombosis in HIT journal September 2018
I NNATE I MMUNE R ECOGNITION journal April 2002
Interferon-α as angiogenesis inhibitor: Learning from tumor models journal February 2010
Scleroderma journal May 2009
β-Defensin 2 and 3 Promote the Uptake of Self or CpG DNA, Enhance IFN-α Production by Human Plasmacytoid Dendritic Cells, and Promote Inflammation journal June 2013
What Can Pleiotropic Proteins in Innate Immunity Teach Us about Bioconjugation and Molecular Design? journal May 2018
LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts: Letter to the Editor journal July 2011
Toll Like Receptors in systemic sclerosis: An emerging target journal March 2018
Structural investigations of DNA-polycation complexes journal January 2005
Fibrosis—a lethal component of systemic sclerosis journal April 2014
Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis journal July 2018
Type I Interferons in Bacterial Infections: A Balancing Act journal December 2016
Engineered nanoparticles interacting with cells: size matters journal January 2014
Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study journal January 2017
Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders journal August 2002
Macrophage Extracellular Traps: A Scoping Review journal October 2017
Structural perspectives on antimicrobial chemokines journal January 2012
Engineered Nanoparticles Interacting with Cells: Size Matters text January 2014
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8 journal January 2018
Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation through Type I Interferon and Interleukin 6 journal August 2003
Plasmacytoid Dendritic Cell Recruitment by Immobilized CXCR3 Ligands journal November 2004
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome journal December 2015
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity journal September 2018
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction journal December 2001
Nika : software for two-dimensional data reduction journal March 2012
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc journal October 2013
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients journal January 2006
Serum CXCL4 increase in primary Sjögren’s syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement journal August 2016
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype journal April 2014
Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9 journal April 2017
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA: Innate immunity journal November 2014
Type I interferon system activation and association with disease manifestations in systemic sclerosis journal May 2010
Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4 journal July 2013
Platelet secretion: From haemostasis to wound healing and beyond journal May 2015
A review of immune amplification via ligand clustering by self-assembled liquid–crystalline DNA complexes journal June 2016
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis journal January 2014
Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors journal March 2018
From The Cover: Higher-order assembly of microtubules by counterions: From hexagonal bundles to living necklaces journal November 2004
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis journal September 2015
Induction of interferon‐α by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon‐α activity with lung fibrosis journal July 2008
Liquid-crystalline ordering of antimicrobial peptide–DNA complexes controls TLR9 activation journal June 2015
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer journal October 2008
BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells journal July 2013
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals journal September 2017
Upregulation of Myxovirus-resistance Protein A: A Possible Marker of Type I Interferon Induction in Systemic Sclerosis journal November 2008
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer journal February 2011
Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation journal October 2016
A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis journal August 2016
Modulation of toll-like receptor signaling by antimicrobial peptides journal April 2019
Biophysical tools to assess the interaction of PF4 with polyanions journal January 2016
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus journal March 2011
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity journal June 2016
Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation. journalarticle January 2017
X-Ray Diffraction in Random Layer Lattices journal May 1941

Cited By (1)

Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis journal May 2019

Figures / Tables (8)